Trade Galectin Therapeutics Inc. - GALT CFD

Trading Conditions

• TypeThis financial market is available for CFD trading.Learn more about:CFDs: CFD
• Spread: 0.0298
• Long position overnight funding adjustmentLong position overnight funding adjustmentMargin. Your investment$1,000.00Overnight funding adjustmentCharges from full value of position-0.022207 %(-$0.44)Trade size with leverage ~ $2,000.00Money from leverage ~ $1,000.00Go to platform: -0.02221%
• Short position overnight funding adjustmentShort position overnight funding adjustmentMargin. Your investment$1,000.00Overnight funding adjustmentCharges from full value of position-0.000015 %(-$0.00)Trade size with leverage ~ $2,000.00Money from leverage ~ $1,000.00Go to platform: -0.00002%
• Overnight funding adjustment time: 21:00 (UTC)
• Currency: USD
• Min traded quantity: 1
• Margin: 50.00%
• Stock exchange: United States of America
• Commission on trade: 0%
• Guaranteed stop premiumA guaranteed stop-loss (GSL) fee is only charged if the GSL is triggered. Please consult the Charges and Fees section of our website for more details.: 1%

• Margin. Your investment: $1,000.00
• Overnight funding adjustmentCharges from full value of position: -0.022207 %
  (-$0.44)

• Margin. Your investment: $1,000.00
• Overnight funding adjustmentCharges from full value of position: -0.000015 %
  (-$0.00)

Key Stats

• Prev. Close: 3.9001
• Open: 3.8151
• 1-Year Change: -9.49%
• Day's Range: 3.7951 - 3.9849

Trade Galectin Therapeutics Inc. - GALT

What is Galectin Therapeutics Inc. (GALT)?

Galectin Therapeutics Inc. is a clinical-stage biotechnology company focused on the development of therapies targeting galectin proteins implicated in fibrotic diseases and cancer. The company’s research centers on inhibiting galectin-3, a protein involved in inflammation, fibrosis, and tumor progression. Galectin Therapeutics develops drug candidates intended to treat conditions such as liver fibrosis, cancer, and other fibrotic disorders. Its activities include preclinical studies, clinical trials, and regulatory interactions. The company collaborates with research institutions and industry partners to advance its therapeutic pipeline. Galectin Therapeutics operates within the biopharmaceutical sector, subject to regulatory oversight by agencies including the Food and Drug Administration. Its governance structure comprises a board of directors and executive leadership responsible for corporate strategy and compliance.

Galectin Therapeutics Inc. Stock Price Today: Live Overview

The price today is shaped by trading fluctuations, as Galectin Therapeutics Inc. is currently at $3.9049. The price range for the day spans from $3.7951 to $3.9949, with a daily change of -0.6368%.

FAQ: Galectin Therapeutics Inc. (GALT)

What is the current price of GALT stock?

The stock currently trades at $3.9049.

Does GALT pay dividends?

Galectin Therapeutics Inc. does not pay dividends.

Does GALT have a formal corporate presence or regional headquarters in the UAE?

Galectin Therapeutics Inc does not have a registered presence in the UAE and operates via partnerships.

What is GALT best known for?

The company is most famous for developing therapies targeting galectin proteins for fibrosis and cancer.

What assets are typically shown together with GALT?

Commonly shown alongside GALT: Volvo - B, ProShares Ultra SmallCap600, Banca Mediolanum S.p.A.